touyun biotech (01332.HK) announced its interim performance for the six months ending in June, with revenue recording 73.05 million yuan, a 30% year-on-year decrease. The loss narrowed from 83.95 million yuan in the same period last year to 47.97 million yuan, with a loss per share of 1.71 cents. No interim dividends will be distributed.
《業績》透雲生物(01332.HK)中期虧損收窄至4,797萬元
The performance of touyun biotech (01332.HK) narrowed its losses in the first half to 47.97 million yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated